News
Arcutis stock sees a 5% dip; Zoryve gains 4th approval, boosting sales. Cash flow breakeven expected by 2026. Read more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback